Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Oncothyreon -- Ignore unavailable to you. Want to Upgrade?

To: John Curtis who wrote (783)	5/17/1999 11:12:00 AM
From: StockMiser	Read Replies (3) \| Respond to of 2344

Actually, BIOM looks great today. Almost all of the ASCO plays gapped down big today, even IMCL which had a couple of very nice bits of news this morning. BIOM, however, gapped up very convincingly. The "sell on news crowd" was predicatble without the NY Times article today, but I honestly believe we're staying in last week's range (5 1/4 - 5 1/2) because of continued expectations for that article. Tomorrow is the Science Times feature, and I think a lot of traders will come in later in the day for that possibility. Given some good volume and some big PR, this morning's action demonstrated that all those $8-10 predictions (for the Times article) are not off-base. On a totally seperate note...someone told me a rumor that Merril is raising it's price target on BIOM to $20. Is this total speculation, or can someone confirm this? SM